GenSci-136

N/A

Report date: 2026/04/16 16:28:48

Base Information

Drug NameGenSci-136
Drug Alias NameGenSci136
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitorsB-cell-activating factor/B lymphocyte stimulator inhibitors
TargetsTumor necrosis factor ligand superfamily member 13B-cell-activating factor/B lymphocyte stimulator
Therapy Area/IndicationsAutoimmune DiseasesGlomerulonephritis, IGAMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesGlomerulonephritis, IGAMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A